%EB%8C%80%EB%AC%B8%EC%9D%B4%EB%AF%B8%EC%

PIPELINES

Nanocontrast

CX4 series

molecular-structure-abstract-science-bac

CX4 series is a contrast agent that can be utilized during MRI; it is a nanozyme, utilizing CX synthetic platform technology, that solves contrast toxicity  currently plaguing existing technologies. It is an innovative material, based on novel nanocatalytic technology, with excellent contrast effects and biostability.

그림3.png

High potency

The CX4 series exhibits optimal contrast effects: inorganic elements show optimal contrast in the MRI, comparable to conventional contrast agent.

그림7.png

Adaptability

그림1.png
그림2.png
그림2.png
그림4.png
그림6.png

Safety

Based on nanocatalytic technology, the CX4 series is non-toxic, has high biostability, and does not suffer from ion elimination, a problem with conventional contrast agent. Moreover, biocompatibility is secured by treatment with a special polymer.

Applicability

Advancing beyond the limitations of previous studies, the structural stability of nanocatalysts ensures that the CX4 series is adaptable for use in patients with underlying diseases that have been recalcitrant to imaging with conventional contrast agent.

Characteristic of nanocatalytic technology, the physical aspects of the nanozymes are extremely customizable. Therefore, the CX4 series can be applied as a contrast agent for the imaging of various nonspecific lesions and organs in the body.